Alejandro Pérez‐Pitarch

Sirolimus exposure and the occurrence of cytomegalovirus DNAemia after allogeneic hematopoietic stem cell transplantation

José Luís Piñana, Alejandro Pérez‐Pitarch, Beatriz Guglieri-López et al. · American Journal of Transplantation · 2018 · 27 citations · Full text

Medicine, Immunology, Pharmacology +17

A Time-to-Event Model for Acute Kidney Injury after Reduced-Intensity Conditioning Stem Cell Transplantation Using a Tacrolimus- and Sirolimus-based Graft-versus-Host Disease Prophylaxis

José Luís Piñana, Alejandro Pérez‐Pitarch, Irene García‐Cadenas et al. · Biology of Blood and Marrow Transplantation · 2017 · 25 citations · Full text

Medicine, Immunology, Nephrology +17

Dosing of caspofungin based on a pharmacokinetic/pharmacodynamic index for the treatment of invasive fungal infections in critically ill patients on continuous venovenous haemodiafiltration

Alejandro Pérez‐Pitarch, Rafael Ferriols‐Lisart, Gerardo Aguilar et al. · International Journal of Antimicrobial Agents · 2017 · 23 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Population pharmacokinetics of lenalidomide in multiple myeloma patients

Beatriz Guglieri-López, Alejandro Pérez‐Pitarch, Dirk Jan A. R. Moes et al. · Cancer Chemotherapy and Pharmacology · 2016 · 17 citations

Pharmacy, Pharmacokinetics, Pharmacology +11

C-Reactive Protein as an Early Predictor of Efficacy in Advanced Non-Small-Cell Lung Cancer Patients: A Tumor Dynamics-Biomarker Modeling Framework

Yomna Nassar, Francis Williams Ojara, Alejandro Pérez‐Pitarch et al. · Cancers · 2023 · 15 citations · Full text

Medicine, Oncology, Pharmacology +17